Acne.
Acne is a chronic disorder of pilosebaceous unit clinically characterized by comedones, papules, pustules, nodules and scarring. It affects almost 85% of young people between 12-24 years of age. Four main pathophysiologic factors that influence the development of acne are; increased sebum secretion,...
| Publicado en: | Turkish Journal of Dermatology / Türk Dermatoloji Dergisi Vol. 6; no. 4; pp. 138 - 150 |
|---|---|
| Autor principal: | |
| Formato: | tables/charts Journal Article |
| Publicado: |
Galenos Yayinevi Tic. LTD. STI
dec2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104411182&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104411182 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 13077635 87WM jtl: Turkish Journal of Dermatology / Türk Dermatoloji Dergisi issn: 13077635 maglogo: N pubinfo: dt: dec2012 vid: 6 iid: 4 pid: 28155 pub: Galenos Yayinevi Tic. LTD. STI artinfo: ui: 104411182 104411182 2011885476 10.5152/tdd.2012.31 104411182 ppf: 138 ppct: 12 formats: fmt: @attributes: type: P tig: atl: Acne. aug: au: Güngör, Emel affil: Acıbadem Fulya Hastanesi, Dikilitaş Mah. Hakkı Yeten Cad. Yeşilçimen Sok. No: 23 34349 Fulya, Beşiktaş, İstanbul, Türkiye sug: subj: Acne Vulgaris Drug Therapy Acne Vulgaris Etiology Acne Vulgaris Physiopathology Administration, Topical Retinoids Therapeutic Use Antiinfective Agents Therapeutic Use Isotretinoin Therapeutic Use Hormone Therapy ab: Acne is a chronic disorder of pilosebaceous unit clinically characterized by comedones, papules, pustules, nodules and scarring. It affects almost 85% of young people between 12-24 years of age. Four main pathophysiologic factors that influence the development of acne are; increased sebum secretion, abnormal follicular desquamation, P. acnes colonization of the follicle and inflammation. The treatment of acne includes; topical retinoids, topical antimicrobial agents, systemic antibiotics, hormonal therapy and oral isotretinoin.Topical retinoids should be used as the first choice in comedonal acne, in combination with topical and/or systemic antimicrobials for mild to moderate inflammatory acne and as maintenance therapy once clearance has been achieved. Topical and system ic antibiotics which are used to treat moderate inflammatory acne should not be used as monotherapy but combined with topical benzoyl peroxide or topical retinoids and should be stopped as soon as possible. Hormonal therapy is an excellent choice for women, especially if oral contraception is desired. It may also be used for female patients with severe seborrhea, late onset acne and with proven hyperandrogenism. Oral isotretinoin targets all pathophysiologic factors in acne and is the mainstay of therapy for severe acne. It has to be kept in mind that the management of acne and compliance of the patient to the treatment can be enhanced by a number of general strategies such as education about acne and treatment, skin care, diet and adjuvant procedures. pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article language: Turkish refInfo: holdings: @attributes: islocal: N |
|---|